Ads
-
Related paper
- Formulation and Characterization of Macitantan Nanoparticles for the Treatment of Pulmonary Hypertension
- Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II
- Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension: Results From a Controlled Before and After Study
- FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF FELODIPINE FOR THE TREATMENT OF HYPERTENSION
- Formulation of Nanoparticles of Rabeprazole Sodium for the Treatment of Peptic Ulcer
- Green Synthesis, Characterization and Evaluation of In-vitro Antioxidant Anti-diabetic Activity of Nanoparticles from a Polyherbal formulation-Mehani
- Formulation and Evaluation of Prolonged Release Transdermal Drug Delivery System of Atenolol for the Treatment of Hypertension
- The Effectiveness of Patient-Oriented Correction of Adherence to Treatment in Patients with Arterial Hypertension and Comorbid Chronic Obstructive Pulmonary Disease
- PULMONARY VENO OCCLUSIVE DISEASE- A RARE CAUSE OF PULMONARY ARTERIAL HYPERTENSION
- STUDY OF THE PULMONARY HYPERTENSION AND PULMONARY VESSELS MEASUREMENTS USING COMPUTED TOMOGRAPHY